OBJECTIVES The goal of this study was to compare regadenoson and dipyridamole hyperemia for quantitative myocardial perfusion imaging.
Additionally, we explored the timing effect of radiotracer injection following the regadenoson bolus.
METHODS
We performed an investigator-initiated, single-center, diagnostic accuracy study at the Weatherhead Investigators, study subjects, and PET center staff performing imaging were not blinded to vasodilator assignment. A minority of subjects received dipyridamole for both scans to quantify its test/retest repeatability. Eleven subjects could not complete both scans and were excluded from the analysis. To screen for drugs that might affect vasodilation, serum and urine samples at each PET scan were tested for caffeine, nicotine, and nicotine's metabolite cotinine.
A sample size of about 50 complete pairs was estimated based on a paired t test with a ¼ 0.05, b ¼ 0.80, variance in stress flow of 0.37 to 0.50, variance in CFR of 0.80 to 0.94 (both derived from our previous work), and the desire to detect differences between 0.2 and 0.5 in stress flow and CFR. After completely enrolling and analyzing this first timing sequence, we decided to study additional timing sequences to construct a response curve. Each timing sequence had a pre-specified sample size based on the variance observed in the first sequence. Therefore, our study consisted of serial mini-trials, each performed and primarily analyzed separately.
CARDIAC PET ACQUISITION AND ANALYSIS. Our imaging protocol has been described previously, and this section follows previous publications closely (7).
Subjects were instructed to fast for 4 h and abstain from caffeine, theophylline, and cigarettes for 24 h. flow or CFR, we employed a mixed-effects ANOVA model that adjusted for its value at rest, hyperemia, and CFR (both). were excluded because they only completed 1 PET scan for a variety of reasons: 6 had a severe clinical event or invasive procedure, 2 were unable to obtain intravenous access, 1 had bronchospasm from dipyridamole (successfully treated by aminophylline alone), and 2 had scheduling issues. Absolute rest and stress heart rates for regadenoson or repeat dipyridamole differed among the timing groups (p ¼ 0.023 and p < 0.001, respectively). However, relative heart rate and blood pressure changes between rest and stress showed no significant differences among the various timing groups. 
RESULTS
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(A to C) Each panel depicts the unitless flow ratio to baseline dipyridamole for the 5 regadenoson (Rega) timing sequences (labeled as "Rega X sec," where the seconds correspond to the red text in Figure 1 ) and repeated dipyridamole (Dipy). Teal dots provide the raw data for each pair, whereas the solid pink bars and red numbers summarize the mean, and the thin pink bars mark 1 SD.
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Regadenoson Versus Dipyridamole Hyperemia Systematic caffeine and nicotine measurements detected 7 subjects with caffeine on both scans, 9 subjects with nicotine or cotinine on both scans, 13 subjects with caffeine on only 1 scan, 12 subjects with tobacco on only 1 scan, and 1 subject with caffeine on only 1 scan, but with cotinine on both scans. Serum caffeine levels were low, median 1.6 mg/l (IQR: 1.3 to 1.9 mg/l), as were tobacco tests for urine nicotine, median 14 ng/ml (IQR: 4 to 120 ng/ml), and cotinine, median 24 ng/ml (IQR: 4 to 182 ng/ml).
Our results did not differ in any significant fashion after excluding the 21 pairs with detectable caffeine at either study.
In However, unlike our results, they found that regadenoson provided superior stress flow compared with dipyridamole or adenosine (3.58 AE 0.58 ml/min/g vs.
2.81 AE 0.67 ml/min/g and 2.78 AE 0.61 ml/min/g, respectively) with similar ordering for CFR (3.11 AE 0.62 vs. 2.61 AE 0.57 and 2.7 AE 0.30, respectively).
Several potential explanations exist, notably the much smaller sample size and different imaging modality compared with our cohort.
FFR shows excellent agreement between regadenoson and adenosine, with no significant bias and 
